Sarah Piron

PhD Thesis
open access

Exploring the potential of [18F]AlF-PSMA-11 for prostate cancer imaging

Sarah Piron (UGent)

(2023)

Impact of 18F-PSMA-11 PET/CT on management of biochemical recurrence and high-risk prostate cancer staging 18F-PSMA-11 PET/CT and impact on prostate cancer management

Kathia De Man (UGent) , Sarah Piron (UGent) , Nick Van Laeken (UGent) , Louke Delrue (UGent) , Valerie Fonteyne (UGent) , Nicolaas Lumen (UGent) , Bliede Van den Broeck (UGent) , Ken Kersemans (UGent) , Piet Ost (UGent) and Vanessa Schelfhout (UGent)

(2022) MOLECULAR IMAGING AND BIOLOGY. 24(5). p.750-758

Add to list

18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial

Kathia De Man (UGent) , Nick Van Laeken (UGent) , Vanessa Schelfhout (UGent) , Wolfgang P. Fendler, Bieke Lambert (UGent) , Ken Kersemans (UGent) , Sarah Piron (UGent) , Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , et al.

(2022) EUROPEAN UROLOGY. 82(5). p.501-509

Add to list

Journal Article
A1
open access

Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors

Sarah Piron (UGent) , Jeroen Verhoeven (UGent) , Jan Courtyn (UGent) , Ken Kersemans (UGent) , Benedicte Descamps (UGent) , Leen Pieters (UGent) , Anne Vral (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2022) SCIENTIFIC REPORTS. 12(1).

Add to list

Journal Article
A1
open access

Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals

Sarah Piron (UGent) , Jeroen Verhoeven (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2022) NUCLEAR MEDICINE AND BIOLOGY. 106-107. p.29-51

Add to list

Journal Article
A1
open access

Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer

Sarah Piron (UGent) , Jeroen Verhoeven (UGent) , Emma De Coster (UGent) , Benedicte Descamps (UGent) , Ken Kersemans (UGent) , Leen Pieters (UGent) , Anne Vral (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2021) SCIENTIFIC REPORTS. 11(1).

Add to list

Journal Article
A1
open access

Intra-individual dynamic comparison of 18F-PSMA-11 and 68Ga-PSMA-11 in LNCaP xenograft bearing mice

Sarah Piron (UGent) , Jeroen Verhoeven (UGent) , Benedicte Descamps (UGent) , Ken Kersemans (UGent) , Kathia De Man (UGent) , Nick Van Laeken (UGent) , Leen Pieters (UGent) , Anne Vral (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2020) SCIENTIFIC REPORTS. 10(1).

Add to list

Journal Article
A1
open access

Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer

Sarah Piron (UGent) , Kathia De Man (UGent) , Vanessa Schelfhout (UGent) , Nick Van Laeken (UGent) , Ken Kersemans (UGent) , Eric Achten (UGent) , Filip De Vos (UGent) and Piet Ost (UGent)

(2020) EJNMMI RESEARCH. 10(1).

Add to list

2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation

Jeroen Verhoeven (UGent) , Tristan Baguet, Sarah Piron (UGent) , Glenn Pauwelyn, Charlotte Bouckaert, Benedicte Descamps (UGent) , Robrecht Raedt (UGent) , Christian Vanhove (UGent) , Filip De Vos (UGent) and Ingeborg Goethals (UGent)

(2020) NUCLEAR MEDICINE AND BIOLOGY. 82-83. p.9-16

Add to list

Radiation dosimetry and biodistribution of 18F-PSMA-11 for PET imaging of prostate cancer

Sarah Piron (UGent) , Kathia De Man (UGent) , Nick Van Laeken (UGent) , Yves D'Asseler (UGent) , Klaus Bacher (UGent) , Ken Kersemans (UGent) , Piet Ost (UGent) , Karel Decaestecker (UGent) , Pieter Deseyne, Valerie Fonteyne (UGent) , et al.

(2019) JOURNAL OF NUCLEAR MEDICINE. 60(12). p.1736-1742

Academic Bibliography

Sarah Piron

Exploring the potential of [18F]AlF-PSMA-11 for prostate cancer imaging

Impact of 18F-PSMA-11 PET/CT on management of biochemical recurrence and high-risk prostate cancer staging 18F-PSMA-11 PET/CT and impact on prostate cancer management

18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial

Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors

Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals

Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer

Intra-individual dynamic comparison of 18F-PSMA-11 and 68Ga-PSMA-11 in LNCaP xenograft bearing mice

Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer

2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation

Radiation dosimetry and biodistribution of 18F-PSMA-11 for PET imaging of prostate cancer

Contents

Support

Contact